The effect of Kineret on brain biomarkers in patients with subarachnoid haemorrhage.
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Anakinra (Primary)
- Indications Subarachnoid haemorrhage
- Focus Pharmacodynamics
- 25 Jun 2010 Status changed from recruiting to completed as reported by United Kingdom Clinical Research Network.
- 25 Jun 2010 Actual end date (30 Apr 2010) added as reported by UKCRN.
- 05 May 2010 United Kingdom Clinical Research Network reports accrual to date changed from 37% to 40%.